Ten Bio builds on years of research into its TenSkin technology, which mimics intact, living skin to provide a tool for skin biology research and product testing. The TenSkin system is positioned as a reliable, consistent alternative to some uses of animal testing and has drawn strong interest from major dermatology and cosmetics companies. The firm has signed research contracts with global companies and anticipates its first products will soon be available in the US market. Headquartered in Dundee, Ten Bio plans to open a laboratory in Kannapolis, North Carolina to serve its US-based customers. The company previously won a Scottish EDGE award, receiving a £65,000 prize package. Recent funding will be used to commercialise TenSkin, continue the roll-out of its service business, and develop further product offerings.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2021